• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病患者白细胞中(2'-5')寡腺苷酸合成酶活性

(2'-5') oligo adenylate synthetase activity in leucocytes of patients with inflammatory bowel disease.

作者信息

Stalnikowicz R, Goder K, Karmeli F, Fiocchi C, Rachmilewitz D

出版信息

Gut. 1985 Jun;26(6):556-61. doi: 10.1136/gut.26.6.556.

DOI:10.1136/gut.26.6.556
PMID:2408970
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1432768/
Abstract

The activity of an interferon induced enzyme, (2',5') oligo adenylate synthetase, was determined in peripheral blood mononuclear cells and granulocytes of patients with inflammatory bowel disease and compared with its activity in cells isolated from normal subjects. In spite of the fact that circulating interferon is detected in patients with inflammatory bowel disease, we failed to see any increase in (2',5') oligo adenylate synthetase activity in these patients. The mean +/- SE enzyme activity given in nmol ATP incorporated into (2',5') isoadenylate oligomers by extracts of 10(5) peripheral blood mononuclear cells/21 hours was in normal subjects 1.84 +/- 0.30 (n = 27), in patients with active Crohn's disease 1.38 +/- 0.15 (n = 20) and in patients with active ulcerative colitis 1.14 +/- 0.23 (n = 21). (2',5') oligo adenylate synthetase activity in granulocytes was also similar in normal subjects and in patients with active ulcerative colitis or Crohn's disease. The enzyme activity in patients with active disease was similar both prior to and during steroid therapy. The low (2',5') oligo adenylate synthetase activity in peripheral blood mononuclear cells and granulocytes of patients with active inflammatory bowel disease may reflect decreased cellular response to interferon or a difference in the type of interferon elevated in viral diseases and in inflammatory bowel disease.

摘要

在炎症性肠病患者的外周血单核细胞和粒细胞中测定了一种干扰素诱导酶,即(2',5')寡腺苷酸合成酶的活性,并将其与从正常受试者分离的细胞中的活性进行了比较。尽管在炎症性肠病患者中检测到循环干扰素,但我们未能在这些患者中观察到(2',5')寡腺苷酸合成酶活性有任何增加。10⁵个外周血单核细胞提取物在21小时内掺入(2',5')异腺苷酸寡聚物中的ATP的平均±标准误酶活性,正常受试者为1.84±0.30(n = 27),活动性克罗恩病患者为1.38±0.15(n = 20),活动性溃疡性结肠炎患者为1.14±0.23(n = 21)。正常受试者以及活动性溃疡性结肠炎或克罗恩病患者的粒细胞中(2',5')寡腺苷酸合成酶活性也相似。活动性疾病患者在类固醇治疗前和治疗期间的酶活性相似。活动性炎症性肠病患者外周血单核细胞和粒细胞中低水平的(2',5')寡腺苷酸合成酶活性可能反映了细胞对干扰素的反应降低,或者病毒疾病和炎症性肠病中升高的干扰素类型存在差异。

相似文献

1
(2'-5') oligo adenylate synthetase activity in leucocytes of patients with inflammatory bowel disease.炎症性肠病患者白细胞中(2'-5')寡腺苷酸合成酶活性
Gut. 1985 Jun;26(6):556-61. doi: 10.1136/gut.26.6.556.
2
Interferon inhibits prostaglandin E2 synthesis and stimulates (2'-5')oligoadenylate synthetase activity in peripheral blood mononuclear cells of inflammatory bowel disease patients.干扰素可抑制炎症性肠病患者外周血单个核细胞中前列腺素E2的合成,并刺激(2'-5')寡腺苷酸合成酶的活性。
J Interferon Res. 1985 Fall;5(4):629-35. doi: 10.1089/jir.1985.5.629.
3
(2'-5')Oligoadenylate synthetase activity in intestinal mononuclear and epithelial cells of inflammatory bowel disease patients.炎症性肠病患者肠道单核细胞和上皮细胞中的(2'-5')寡腺苷酸合成酶活性
Scand J Gastroenterol. 1988 Oct;23(8):941-7. doi: 10.3109/00365528809090151.
4
Oligo-2',5'-adenylate synthetase activity in peripheral blood mononuclear leukocytes in various diseases.多种疾病中外周血单个核白细胞的寡聚2',5'-腺苷酸合成酶活性
J Clin Microbiol. 1984 Dec;20(6):1216-8. doi: 10.1128/jcm.20.6.1216-1218.1984.
5
[Study of serum 2-5AS activity and NK cell activity in the patients with Crohn's disease and ulcerative colitis].克罗恩病和溃疡性结肠炎患者血清2-5寡腺苷酸合成酶活性及自然杀伤细胞活性的研究
Nihon Shokakibyo Gakkai Zasshi. 1988 Jan;85(1):14-9.
6
Variation of (2'-5') oligo A synthetase level in lymphocytes and granulocytes of patients with viral infections and leukemia.病毒感染和白血病患者淋巴细胞及粒细胞中(2'-5')寡腺苷酸合成酶水平的变化
J Interferon Res. 1982;2(3):355-61. doi: 10.1089/jir.1982.2.355.
7
Increased activity of oligo-2',5'-adenylate synthetase in Down's syndrome and epilepsy.唐氏综合征和癫痫中寡聚2',5'-腺苷酸合成酶活性增加。
Clin Exp Immunol. 1987 Apr;68(1):168-76.
8
Interferon and 2',5'-oligo(A) synthetase activities in serum and blood mononuclear leukocytes of cattle after injection of bovine interferon-alpha 1.
Am J Vet Res. 1990 Jun;51(6):886-92.
9
Comparison of (2'-5') oligo-adenylate synthetase and interferon blood-levels in mice early after viral infection.病毒感染后早期小鼠体内(2'-5')寡腺苷酸合成酶与干扰素血药浓度的比较。
J Interferon Res. 1982;2(2):285-9. doi: 10.1089/jir.1982.2.285.
10
Lysozyme in plasma and neutrophilic granulocytes in ulcerative colitis and Crohn's disease.溃疡性结肠炎和克罗恩病患者血浆中的溶菌酶及中性粒细胞
Scand J Gastroenterol. 1977;12(2):135-40. doi: 10.1203/00006450-199404000-00011.

引用本文的文献

1
Enteropathogenic Escherichia coli inhibits type I interferon- and RNase L-mediated host defense to disrupt intestinal epithelial cell barrier function.肠致病性大肠杆菌抑制 I 型干扰素和核糖核酸酶 L 介导的宿主防御,破坏肠道上皮细胞屏障功能。
Infect Immun. 2014 Jul;82(7):2802-14. doi: 10.1128/IAI.00105-14. Epub 2014 Apr 14.
2
Interferon gamma production by human intestinal mucosal mononuclear cells. Decreased levels in inflammatory bowel disease.人肠道黏膜单核细胞产生的干扰素γ。炎症性肠病中水平降低。
Dig Dis Sci. 1988 Oct;33(10):1297-304. doi: 10.1007/BF01536683.
3
Production of inflammatory cytokines in the intestinal lamina propria.肠道固有层中炎性细胞因子的产生。
Immunol Res. 1991;10(3-4):239-46. doi: 10.1007/BF02919699.
4
The role of interferon gamma in the pathogenesis of Crohn's disease.干扰素γ在克罗恩病发病机制中的作用。
Gastroenterol Jpn. 1992 Feb;27(1):29-36.

本文引用的文献

1
Conversion of the reactive sulfhydryl groups of proteins to the S-trifluoroethyl derivatives. Application to human hemoglobin.蛋白质的活性巯基转化为S-三氟乙基衍生物。应用于人类血红蛋白。
Anal Biochem. 1981 Jan 1;110(1):19-26. doi: 10.1016/0003-2697(81)90105-6.
2
Impaired natural killer cell activity in patients with inflammatory bowel disease: evidence for a qualitative defect.炎症性肠病患者自然杀伤细胞活性受损:定性缺陷的证据。
Gastroenterology. 1983 Oct;85(4):846-51.
3
Preferential effect of gamma interferon on the synthesis of HLA antigens and their mRNAs in human cells.γ干扰素对人细胞中HLA抗原及其mRNA合成的优先作用。
Nature. 1982 Oct 28;299(5886):833-6. doi: 10.1038/299833a0.
4
Evaluation of the human interferon system in viral disease.病毒性疾病中人类干扰素系统的评估。
Clin Exp Immunol. 1981 Dec;46(3):475-83.
5
Assay of an interferon-induced enzyme in white blood cells as a diagnostic aid in viral diseases.
Lancet. 1981 Sep 5;2(8245):497-500. doi: 10.1016/s0140-6736(81)90883-7.
6
Increased levels of (2'-5')oligo(A) polymerase activity in human lymphoblastoid cells treated with glucocorticoids.用糖皮质激素处理的人淋巴母细胞中(2'-5')寡腺苷酸聚合酶活性水平升高。
Proc Natl Acad Sci U S A. 1980 Nov;77(11):6506-10. doi: 10.1073/pnas.77.11.6506.
7
Natural killer cells: characteristics and regulation of activity.自然杀伤细胞:特性与活性调节
Immunol Rev. 1979;44:43-70. doi: 10.1111/j.1600-065x.1979.tb00267.x.
8
Time and dosage dependence of immunoenhancement by murine type II interferon preparations.小鼠II型干扰素制剂免疫增强作用的时间和剂量依赖性
Cell Immunol. 1978 Oct;40(2):285-93. doi: 10.1016/0008-8749(78)90336-2.
9
Decreased suppressor cell activity in inflammatory bowel disease.炎症性肠病中抑制细胞活性降低。
Clin Exp Immunol. 1978 Jun;32(3):451-8.
10
Circulating immune complexes and disease activity in Crohn's disease.克罗恩病中的循环免疫复合物与疾病活动度
Gut. 1978 Jul;19(7):611-7. doi: 10.1136/gut.19.7.611.